Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Adani Group in Talks with Odisha on Nuclear Power Projects, Plans Two 3,000 MW Clean Energy Facilities
India's Adani Group is accelerating its industrial footprint in Odisha, with nuclear power, clean energy, mining, aluminum, and port infrastructure emerging as key priorities in recent discussions. Senior executives of the group recently held talks with Odisha government officials to discuss advancing a range of energy and industrial projects in the state, including two proposed 3,000 MW power generation facilities and an integrated coal gasification and coal-to-chemicals project with an investment of approximately INR 800 billion. Karan Adani, CEO of Adani Ports and Special Economic Zone Ltd...
2026-08-17
India Releases Draft Rules Accompanying SHANTI Act, Requiring Nuclear Power Operators to Provide Nuclear Damage Insurance or Financial Guarantees
2026-08-17
Bulgaria's Kozloduy NPP Addresses Challenges of Low Danube River Water Levels
2026-08-17
SPIC Shandong Nuclear Power's Total Intellectual Property Achievements Surpass 1,000
2026-08-17
US experiment reveals diamond melting behavior under high pressure, potentially advancing inertial confinement fusion research
2026-08-17
Machine learning framework predicts micro-displacements of DIII-D fusion device coils
2026-08-17
Installation of the fifth tier of the inner containment shell begins at Unit 1 of Egypt's El Dabaa Nuclear Power Plant
2026-08-17
St. Lucie Nuclear Power Plant Unit 1 Manually Shut Down After Three Control Rods Dropped into the Core
2026-08-17
4.4-Magnitude Earthquake Hits Fukuoka Area; Kyushu Electric Says No Abnormalities at Genkai and Sendai Nuclear Plants
2026-08-17
The Korea AeroSpace Administration (KASA) announced on August 17 that the Lunar Space Radiation Detector (LVRAD), independently developed by South Korea, will be mounted on a lander under NASA's Commercial Lunar Payload Services (CLPS) program to conduct observations of the radiation environment on the lunar south pole surface. The two sides signed the relevant implementation agreement on August 14. Under the agreement, KASA plans to complete the development of the flight model of the detector by next year and deliver the equipment to the United States in accordance with the NASA lunar lander mission schedule. NASA will be responsible for integrating the Korean-developed detector onto the commercial lunar lander and supporting its operation and data transmission on the lunar surface after launch. LVRAD consists of...
2026-08-17
A research team at Seoul Metropolitan Government Seoul National University Boramae Medical Center has recently developed an artificial intelligence model capable of identifying bone metastases that are difficult to detect on CT images. By incorporating MRI and PET/CT information during the training process, the model enables lesions that are inconspicuous on CT and prone to being missed to be included in the training data, thereby enhancing detection capability. Bone metastasis is an important basis for determining cancer staging and formulating treatment plans. If lesions are not clearly visible on CT images, bone metastasis may be detected late and may lead to complications such as pathological fractures and spinal cord compression. Previous related AI studies have largely relied on lesions clearly visible on CT to build training data, and the research team believes that this approach may...
2026-08-17
The Turkish Nuclear Regulatory Authority has issued an operating license for the TR-2 research reactor at the Istanbul campus of the Nuclear Energy Institute under the Turkish Energy, Nuclear and Mineral Research Agency (TENMAK). The license was issued pursuant to the Authority's Decision No. 2026-34/3 dated August 6, 2026. Following the review and evaluation of TENMAK's application documents, the Turkish Nuclear Regulatory Authority authorized the agency to carry out the activities required for the transition of the TR-2 research reactor from its current status to the operational phase. TR-2 is located at the Istanbul campus of TENMAK's Nuclear Energy Institute, with an approved thermal power of 5 megawatts. The facility is a research reactor and is not a nuclear facility primarily intended for power generation. According to...
2026-08-17
Recently, the public announcement of winning bidder candidates for the civil construction project of the Huludao Research Reactor Project of the China Institute of Atomic Energy was released. The announcement shows that China Nuclear Industry 24 Construction Co., Ltd. ranks as the first winning bidder candidate with a bid price of RMB 1,109,080,000.00; China Nuclear Industry Huaxing Construction Co., Ltd. ranks as the second winning bidder candidate with a bid price of RMB 1,109,100,279.50. The tendered project is the research reactor project of the China Institute of Atomic Energy, with the scope of tender covering the civil construction works of the research reactor project, and the construction site located in Xingcheng City, Huludao City, Liaoning Province. The maximum bid limit for the project is RMB 1,109,550,000.00, and the maximum bid limit for daywork is RMB 320 per workday, excluding tax. According to...
2026-08-17
The U.S. Nuclear Regulatory Commission recently announced it will hold an online public meeting from 1:00 p.m. to 2:30 p.m. Eastern Time on August 20 to introduce the proposed rule aimed at reducing barriers to medical use licensing. The proposed rule was published in the Federal Register on July 27. During the meeting, NRC staff will outline the key provisions of the rule and related implementation activities, and answer questions from the public. The meeting is open to the public and will focus on regulatory processes related to medical use licensing, with the goal of explaining and discussing the proposed rule and subsequent implementation arrangements...
2026-08-16
The U.S. Food and Drug Administration has approved Tauklarify, a new brain imaging agent for the evaluation of Alzheimer's disease. The drug, also known as MK-6240, is a radioactive diagnostic agent for positron emission tomography (PET) in adults, primarily indicated for adults with cognitive impairment who require physician assessment of abnormal tau protein accumulation in the brain. The twisted, insoluble fibrous deposits formed by tau protein are believed to be associated with neurodegenerative diseases such as Alzheimer's disease. The developer, Lantheus, stated that the safety of Tauklarify was evaluated in two clinical trials involving more than 1,700 subjects. Adverse reactions...
2026-08-16
U.S. health technology company Function Health recently secured $450 million in growth funding from General Catalyst's Customer Value Fund. The company stated that the funds will be used to expand user coverage of its testing and medical imaging platform. Function Health launched as a beta version in 2023, with a platform integrating laboratory testing, medical imaging, and health data analytics services. Its membership includes over 160 laboratory tests, with testing scheduled twice a year, and annual plans starting at $365. Testing coverage encompasses cardiovascular health, hormones, thyroid and kidney function, inflammation, nutritional levels, and certain cancers...
2026-08-16
